Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2.

Biochemical and biophysical research communications - 27 Nov 1998

Iacobazzi V, Naglieri M A, Stanley C A, Wanders R J, Palmieri F

Abstract excerpt

The carnitine/acylcarnitine translocase (CACT) transports acylcarnitines into mitochondria in exchange for free carnitine and it is, therefore, essential for the fatty acid beta-oxidation pathway. We have determined the exon-intron structure of the human CACT gene, which is responsible for a genetic disorder of fatty acid oxidation called CACT deficiency. The gene spans about 16.5 kb and consists of nine exons...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cloning, Molecular
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Primers

Share to Molecular Sequence Data

Share to Mutation

Share to Polymerase Chain Reaction

Share to Sequence Deletion

Source

Identifiers

PMID: 9837782
DOI: 10.1006/bbrc.1998.9738

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2.PMID 9837782Read ↗

Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency.Semantic proximity Read ↗

Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals.Semantic proximity Read ↗

Organization of the human liver carnitine palmitoyltransferase 1 gene ( CPT1A) and identification of novel mutations in hypoketotic hypoglycaemia.Semantic proximity Read ↗

Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.Semantic proximity Read ↗

Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.Semantic proximity Read ↗

Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant.Semantic proximity Read ↗

Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.Semantic proximity Read ↗

Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency.Semantic proximity Read ↗

Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency.Semantic proximity Read ↗

Structure and function of carnitine acyltransferases.Semantic proximity Read ↗

Functional analysis of mutations in the human carnitine/acylcarnitine translocase in Aspergillus nidulans.Semantic proximity Read ↗

Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.